S. Corya

1.6k total citations
26 papers, 1.1k citations indexed

About

S. Corya is a scholar working on Psychiatry and Mental health, Pharmacology and Clinical Psychology. According to data from OpenAlex, S. Corya has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Psychiatry and Mental health, 11 papers in Pharmacology and 6 papers in Clinical Psychology. Recurrent topics in S. Corya's work include Bipolar Disorder and Treatment (14 papers), Treatment of Major Depression (11 papers) and Electroconvulsive Therapy Studies (10 papers). S. Corya is often cited by papers focused on Bipolar Disorder and Treatment (14 papers), Treatment of Major Depression (11 papers) and Electroconvulsive Therapy Studies (10 papers). S. Corya collaborates with scholars based in United States, Spain and Germany. S. Corya's co-authors include Michael Case, Olawale Osuntokun, T.M. Sanger, Susan D. Briggs, Alexandra N. Heinloth, Richard C. Shelton, Gary D. Tollefson, Holland C. Detke, Sanjay Dubé and Daniel Lin and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Affective Disorders and Schizophrenia Research.

In The Last Decade

S. Corya

23 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Corya United States	13	783	653	202	197	117	26	1.1k
WFSBP Task Force on Treatment Guide United States	8	1.1k 1.4×	408 0.6×	144 0.7×	274 1.4×	190 1.6×	8	1.4k
Wolfram Bender Germany	16	408 0.5×	418 0.6×	184 0.9×	220 1.1×	256 2.2×	30	952
Harm J. Gijsman Netherlands	17	811 1.0×	359 0.5×	96 0.5×	287 1.5×	119 1.0×	28	1.4k
Rebecca Schennach-Wolff Germany	18	728 0.9×	254 0.4×	286 1.4×	225 1.1×	231 2.0×	29	1.2k
Anthony S. Hale United Kingdom	19	405 0.5×	373 0.6×	256 1.3×	230 1.2×	237 2.0×	46	1.3k
Mary Hobart United States	20	1.2k 1.5×	785 1.2×	136 0.7×	215 1.1×	185 1.6×	49	1.6k
M. Patricia Ball United States	16	572 0.7×	246 0.4×	194 1.0×	109 0.6×	93 0.8×	17	1.2k
Yuki Matsuda Japan	19	587 0.7×	242 0.4×	152 0.8×	117 0.6×	141 1.2×	77	1.2k
Shamsah B. Sonawalla United States	19	364 0.5×	341 0.5×	162 0.8×	278 1.4×	245 2.1×	30	1.1k
Jamie Mullen United States	14	1.4k 1.8×	328 0.5×	89 0.4×	139 0.7×	55 0.5×	23	1.7k

Countries citing papers authored by S. Corya

Since Specialization

Citations

This map shows the geographic impact of S. Corya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Corya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Corya more than expected).

Fields of papers citing papers by S. Corya

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Corya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Corya. The network helps show where S. Corya may publish in the future.

Co-authorship network of co-authors of S. Corya

This figure shows the co-authorship network connecting the top 25 collaborators of S. Corya. A scholar is included among the top collaborators of S. Corya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Corya. S. Corya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zanarini, Mary C., S. Charles Schulz, Holland C. Detke, et al.. (2012). Open-Label Treatment With Olanzapine for Patients With Borderline Personality Disorder. Journal of Clinical Psychopharmacology. 32(3). 398–402. 11 indexed citations

Zanarini, Mary C., S. Charles Schulz, Holland C. Detke, et al.. (2011). A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder. The Journal of Clinical Psychiatry. 72(10). 1353–1362. 42 indexed citations

Shelton, Richard C., Olawale Osuntokun, Alexandra N. Heinloth, & S. Corya. (2010). Therapeutic Options for Treatment-Resistant Depression. CNS Drugs. 24(2). 131–161. 166 indexed citations

Detke, Holland C., David McDonnell, Eric J. Brunner, et al.. (2010). Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases. BMC Psychiatry. 10(1). 43–43. 82 indexed citations

Osuntokun, Olawale, Brian A. Millen, Wen Xu, et al.. (2010). Metabolic parameters in patients treated with olanzapine or other atypical antipsychotics. Journal of Psychopharmacology. 25(5). 630–638. 8 indexed citations

Trivedi, Madhukar H., Michael E. Thase, Olawale Osuntokun, et al.. (2009). An Integrated Analysis of Olanzapine/Fluoxetine Combination in Clinical Trials of Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 70(3). 387–396. 50 indexed citations

Schulz, S. Charles, Mary C. Zanarini, Anthony Bateman, et al.. (2008). Olanzapine for the treatment of borderline personality disorder: variable dose 12-week randomised double-blind placebo-controlled study. The British Journal of Psychiatry. 193(6). 485–492. 72 indexed citations

Osuntokun, Olawale, Brian A. Millen, Ludmila Kryzhanovskaya, et al.. (2008). METABOLIC PARAMETERS IN PATIENTS TREATED WITH OLANZAPINE OROTHER ATYPICAL ANTIPSYCHOTICS. Schizophrenia Research. 102(1-3). 243–243. 1 indexed citations

Thase, Michael E., S. Corya, Olawale Osuntokun, et al.. (2007). A Randomized, Double-Blind Comparison of Olanzapine/Fluoxetine Combination, Olanzapine, and Fluoxetine in Treatment-Resistant Major Depressive Disorder. The Journal of Clinical Psychiatry. 68(2). 224–236. 171 indexed citations

10.

Schulz, S. Charles, Mary C. Zanarini, Holland C. Detke, et al.. (2007). Olanzapine for the treatment of borderline personality disorder: A flexible-dose 12-week randomized double-blind placebo-controlled study. European Psychiatry. 22. S172–S172. 5 indexed citations

11.

Zanarini, Mary C., S. Charles Schulz, Holland C. Detke, et al.. (2007). A dose comparison of olanzapine for the treatment of borderline personality disorder: A 12-week randomized double-blind placebo-controlled study. European Psychiatry. 22. S172–S173. 12 indexed citations

12.

Corya, S., et al.. (2006). A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression. Depression and Anxiety. 23(6). 364–372. 129 indexed citations

13.

Corya, S., Roy H. Perlis, Paul E. Keck, et al.. (2006). A 24-Week Open-Label Extension Study of Olanzapine-Fluoxetine Combination and Olanzapine Monotherapy in the Treatment of Bipolar Depression. The Journal of Clinical Psychiatry. 67(5). 798–806. 44 indexed citations

14.

Shelton, Richard C., Douglas J. Williamson, S. Corya, et al.. (2005). Olanzapine/Fluoxetine Combination for Treatment-Resistant Depression. The Journal of Clinical Psychiatry. 66(10). 1289–1297. 130 indexed citations

15.

Keck, Paul E., S. Corya, Lori L. Altshuler, et al.. (2005). Analyses of Treatment-Emergent Mania With Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression. The Journal of Clinical Psychiatry. 66(5). 611–611. 43 indexed citations

16.

Andersen, Scott W., David B. Clemow, & S. Corya. (2005). Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder. The Journal of Clinical Psychiatry. 66(11). 1468–1476. 38 indexed citations

17.

Corya, S., Scott W. Andersen, Holland C. Detke, et al.. (2003). Long-Term Antidepressant Efficacy and Safety of Olanzapine/Fluoxetine Combination. The Journal of Clinical Psychiatry. 64(11). 1349–1356. 55 indexed citations

18.

Vieta, Eduard, M. Tohen, Terence A. Ketter, et al.. (2003). P.1.078 Long-term use of olanzapine or olanzapine/fluoxetine for bipolar depression. European Neuropsychopharmacology. 13. S207–S208. 1 indexed citations

19.

Keck, P E, S. Corya, Susan D. Briggs, M. Case, & Mauricio Tohen. (2003). P.1.089 Analysis of treatment-emergent mania with olanzapine/fluoxetine combination. European Neuropsychopharmacology. 13. S212–S212. 1 indexed citations

20.

Dubé, Sanjay, et al.. (2002). Olanzapine-fluoxetine combination in treatment-resistant depression. European Psychiatry. 17. 98–98. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact